Zura Bio
ZURA
17 hedge funds and large institutions have $31.6M invested in Zura Bio in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
23.27% more ownership
Funds ownership: 0% → 23.27% (+23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$11.7M |
| 2 |
Boussard & Gavaudan Investment Management
London,
United Kingdom
|
+$3.68M |
| 3 |
Spring Creek Capital
Wichita,
Kansas
|
+$2.94M |
| 4 |
UBS O'Connor
Chicago,
Illinois
|
+$2.46M |
| 5 |
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$2.45M |
Top Sellers
ZURA Hedge Fund Activity: Q3 2021 in Review
17 of the 5,732 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q3 2021, worth a combined $31.6M.
Buyers outnumbered sellers: 17 funds opened new ZURA positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $11.7M.
- 17 institutional investors held Zura Bio (ZURA) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $31.6M of Zura Bio stock for Q3 2021.
- 17 funds opened new Zura Bio positions in Q3 2021 and 0 closed out, a net change of +17 holders.
- The largest Zura Bio buyer in Q3 2021 was Hudson Bay Capital Management, an estimated $11.7M added.
Based on aggregated 13F filings for Q3 2021.